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The composition of the human microbiota influences tumorigenesis, notably in colorectal
cancer (CRC). Pathogenic Escherichia coli possesses a variety of virulent factors, among
them the Cytolethal Distending Toxin (CDT). CDT displays dual DNase and phosphatase
activities and induces DNA double strand breaks, cell cycle arrest and apoptosis in
a broad range of mammalian cells. As CDT could promote malignant transformation,
we investigated the cellular outcomes induced by acute and chronic exposures to E.
coli CDT in normal human colon epithelial cells (HCECs). Moreover, we conducted a
comparative study between isogenic derivatives cell lines of the normal HCECs in order
to mimic the mutation of three major genes found in CRC genetic models: APC, KRAS,
and TP53. Our results demonstrate that APC and p53 deficient cells showed impaired
DNA damage response after CDT exposure, whereas HCECs expressing oncogenic
KRASV12 were more resistant to CDT. Compared to normal HCECs, the precancerous
derivatives exhibit hallmarks of malignant transformation after a chronic exposure to CDT.
HCECs defective in APC and p53 showed enhanced anchorage independent growth
and genetic instability, assessed by the micronucleus formation assay. In contrast, the
ability to grow independently of anchorage was not impacted by CDT chronic exposure
in KRASV12 HCECs, but micronucleus formation is dramatically increased. Thus, CDT
does not initiate CRC by itself, but may have promoting effects in premalignant HCECs,
involving different mechanisms in function of the genetic alterations associated to CRC.
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INTRODUCTION
The Cytolethal Distending Toxin (CDT) is a virulence factor produced by many pathogenic
Gram-negative bacteria including Aggregatibacter actinomycetemcomitans, Campylobacter spp.,
Haemophilus ducreyi, Helicobacter species, or Escherichia coli (E. coli) (Jinadasa et al., 2011). CDT
belongs to the AB2-type of toxin and is composed of three subunits: CdtA and CdtC represent the
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regulatory moiety whereas the catalytic activity relies on CdtB
(Lara-Tejero and Galán, 2000). CDT exposure generally leads to
cellular consequences which depend on CdtB activity, starting
from cell cycle arrest to cell distention and eventually senescence
or apoptosis (Johnson and Lior, 1987; Pérès et al., 1997;
Gelfanova et al., 1999; Blazkova et al., 2010). CdtB shares some
sequence and structural similarities with the metal-dependent
phosphodiesterase family (Dlakic´, 2000), and exhibits dual
catalytic activities, both of which being necessary to mediate
the CDT-related cellular defects. First, CdtB possesses a nuclease
activity reminiscent to that of mammalian DNase I (Elwell and
Dreyfus, 2000). Infection of human cells with a catalytically
active CDT induces the formation of DNA strand breaks
that subsequently activate the DNA damage response (Fedor
et al., 2013; Fahrer et al., 2014). In contrast, CdtB displays
a phosphatidylinositol-3,4,5-triphosphate (PIP3) phosphatase
activity that perturbs the PI-3K/PIP3/Akt/pGSK3β signaling
pathway (Shenker et al., 2007, 2016).
The first CDT-positive bacterial strains were isolated
from children with gastroenteritis (Johnson and Lior,
1987). Epidemiological and in vivo studies support that
CDT contributes to microbial pathogenicity by enhancing
bacterial colonization and tissue inflammation, but the precise
mechanisms still need to be elucidated (Ge et al., 2008). In
mice models, infection with CDT-positive Camplyobacter
jejuni is associated with gastritis and gastric dysplasia (Fox
et al., 2004), and infection with CDT-positive H. hepaticus is
accompanied with hepatitis and hepatic dysplastic nodules (Ge
et al., 2007). These studies could be interpreted to suggest that
CDT participates in the acquisition of a tumorigenic phenotype,
probably through the induction of DNA damage. Actually,
chronic exposure of mammalian cells with sublethal doses of
CDT promotes the acquisition of cancer cells characteristics,
namely genetic instability, enhanced anchorage-independent
growth and defective DNA damage responses (Guidi et al.,
2013). Thus, according to the growing evidence of bacterial
infection associated with increased risk of cancer (Bultman,
2014), deciphering the possible role of CDT in the induction or
promotion of carcinogenesis in different niches is of particular
concern.
Colorectal cancer (CRC) is a leading cause of cancer-related
mortality worldwide in both men and women. Sporadic cancers
represent the majority of CRC cases, and only 5–10% are
attributable to inherited mutations of familial cancer syndromes
(Pancione et al., 2012). Genetic models of CRC identified
key tumor suppressors and oncogenes whose mutations drive
multiple pathways for CRC progression from healthy tissue
to dysplastic adenoma and finally carcinoma (Fearon and
Vogelstein, 1990). Truncating mutations in the adenomatous
polyposis coli (APC) tumor suppressor is considered as one of
the earliest genetic change during CRC, occurring in 70–80%
cases. APC plays a role in a large spectrum of pathways such
as cell adhesion and migration, cell cycle control, apoptosis,
chromosome segregation, Wnt/β-catenin signaling (Fearnhead
et al., 2001), and has been implicated more recently in DNA
repair regulation (Narayan and Sharma, 2015). Kirsten-ras
(KRAS) is a critical oncogene mutated in up to 40% of CRC
(Kiyokawa and Minato, 2014). KRAS encodes a small GTPase
and plays a key role in transduction of extracellular mitogenic
signals to control cell proliferation. Finally, the tumor suppressor
TP53 (p53), a multi-functional transcription factor mutated in
up to 70% of CRC, regulates genes involved in cell cycle control,
apoptosis, senescence and DNA repair in response to DNA
damage and other cellular stresses (Toledo and Wahl, 2006).
Several parameters influence CRC, including bacterial
pathogens from the gut microbiota that represent important
risk factors (Allen-Vercoe and Jobin, 2014; Yu and Fang, 2015).
Various bacteria have been associated with CRC including E. coli,
the major component of the intestinal flora (Swidsinski et al.,
1998; Arthur et al., 2012; Buc et al., 2013; Allen-Vercoe and Jobin,
2014; Bonnet et al., 2014). Pathogenic E. coli possesses numerous
virulence factors important for host tissue colonization, some
of which potentially may be implicated in CRC initiation or
progression. Indeed, colibactin, the product of the polyketide
synthases (pks) pathogenicity island, has been shown to enhance
tumor multiplicity and invasion in mice models of CRC,
probably through its genotoxic potential (Arthur et al., 2012).
Other virulence factors from pathogenic E. coli have been
associated with human CRC, including CDT (Buc et al., 2013;
Bonnet et al., 2014). As colibactin and CDT are the two only
known DNA damaging toxins produced by E. coli, this raises the
question of the carcinogenic potential of CDT during CRC.
In this study, we analyzed the consequences of CDT-I from E.
coli (EcolCDT) exposure on a colonic cell culture model. As we
aimed to observe the possible acquisition of some hallmarks of
cancer, we worked on non-transformed human colonic epithelial
cells (HCEC) derived from healthy patient biopsies. These cells
have been immortalized with the non-oncogenic proteins cyclin-
dependent kinase 4 (Cdk4) and the catalytic component of the
human ribonucleoprotein enzyme telomerase (hTERT) (Roig
et al., 2010), a strategy used to immortalize various epithelial
cell types without conferring tumorigenic properties. The cellular
defects induced by CDT have been compared between isogenic
derivative cell lines mimicking the mutation of three major
genes found in CRC genetic models: loss of APC and TP53, and
ectopic expression of KRAS (Smith et al., 2002). In the present
studies these isogenically experimentally derived cells have been
chronically exposed to sublethal doses of EcolCDT and analyzed
for cancer hallmark acquisition. This study will allow for a better
understanding of the carcinogenic potential of CDT from E. coli
in normal or preneoplasic colonic tissues.
MATERIALS AND METHODS
Chemicals and Supplements for
Cell-Culture Media
The cytolethal distending toxin from E. coli (CDT-I) was
produced and purified in the lab at 25 mg/ml (Fedor et al.,
2013) and preserved in 10% glycerol PBS (Sigma-Aldrich). Fetal
Bovine Serum (FBS), puromycin, hydromycin, and zeocin were
provided by Fisher Scientific. Epidermal growth factor (EGF),
hydrocortisone, insulin, transferrin, sodium selenite (5 nM), and
Gentamycin sulfate (50 µg/ml) were provided by Sigma-Aldrich.
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Antibodies
Anti 53BP1 (Novus Biological) from rabbit is diluted 1/3000
in PBS containing 3% bovine serum albumin (BSA), and anti
γH2AX (Merck/Millipore) from mouse is diluted 1/3000. For
In-Cell Western, anti γH2AX (Cell Signaling technology) from
rabbit was diluted 1/200 in PBS containing 2% fetal bovine serum
(FBS) and 0.2% Triton X-100 (PST buffer).
Alexa fluor 546 from rabbit and 488 (Invitrogen) from mouse
were diluted 1/800 in PBS. Goat anti-rabbit antibody coupled
with 770-nm fluorophore (diluted 1/1000 in PST buffer) and
RedDot2 (diluted 1/1000 in PST buffer) were purchased from
Biotium.
Anti β-catenin (mouse monoclonal, Santa Cruz technologies),
Phalloidin-TRITC (Sigma-Aldrich) and Chicken anti-mouse
Alexa 488 (Fisher scientific) were diluted 1/100, 1/10,000, and
1/2000, respectively, in PBS containing 3% BSA and 0.1% Triton
X-100.
APC protein was detected by a mouse monoclonal antibody
(Ab1, clone FE9) against the N-terminal end (Calbiochem)
and lamins A/C with a monoclonal antibody (clone 4C11,
Sigma-Aldrich). Donkey anti-mouse IgG DyLight 800 conjugate
(Thermoscientific) was used as secondary antibody. Anti
APC, anti lamin and secondary antibody were diluted in
TBS/BSA3%/0.1% Tween (1/100; 1/10,000, and 1/20,000,
respectively).
Cell Lines and Maintenance
Human colonic epithelial cell (HCECs), generated and provided
by Pr Jerry W Shay, were maintained on PrimariaTM flask
in a humidified atmosphere with 5% CO2 at 37
◦C, in 4:1
high-glucose Dulbecco modified Eagle medium/medium 199
supplemented with 2% FBS, epidermal growth factor (EGF
20 ng/ml), hydrocortisone (1 mg/ml), insulin (10 mg/ml),
transferrin (2 mg/ml), sodium selenite (5 nM), and Gentamycin
sulfate (50 µg/ml). In addition, CTA cells were selected by
puromycin (1 µg/ml), CTR cells by hygromycin (200 µg/ml) and
CTP cells by zeocin (1 mg/ml).
For HCECs chronic exposure, 25 pg/ml of CDT were added
at each passage for 2–8 weeks before cells are used in additional
experiments.
1CT, 1CTA, 1CTR, 1CTP were genotyped by STR profiling
using the Gene Print 10 System (Promega). The gene Print
10 system is composed of nine STR loci, including THO1,
TPOX, vWA, CSF1PO, D16S539, D7S820, D13S317, D21S11,
D5S818, and the sex chromosome marker Amelogenin (Amel).
Amplification was done using 10 ng of template DNA
applying the Gene Print 10 system following the manufacturer’s
recommendation. Multiplex PCR reactions were carried out by
using fluorescent dye-linked primers. Labeled products were
detected by electrophoretic size fractionation on an ABI 3130xl
genetic analyzer (Life Technologies). The data were analyzed
by using Gene Mapper ID-X software (Life technologies) to
categorize peaks according to their size in relation to an internal
standard run. This analysis enabled every peak to be allocated a
size corresponding to the number of repeat units present. STR
profiling of each cell line confirms that the cell lines are isogenic
(Supplementary Table 1).
Viability Assay
Cell viability was first determined using the PrestoBlue Cell
Viability Reagent (Invitrogen) according to the manufacturer’s
instructions. HCECs were grown on PrimariaTM 96 well plates
(64,000 cells/well) during 24 h. Then, cells were incubated in
duplicate at three concentrations of CDT (2.5, 0.25, 0.025µg/ml).
After 72 h of treatment, cells were incubated with the PrestoBlue
Cell Viability Reagent (1X) for 10 min at 37◦C and fluorescence
(560 nm excitation, 590 nm emission) was read using an Infinite
200 PRO reader (TECAN). The percentage of cytotoxicity
was determined by comparing results with non-treated
cells.
For the crystal violet proliferation assay, 6000 HCECs were
grown for 24 h in 24-well plates before being treated with
CDT for 5 days. After a PBS wash, cells were fixed for 10 min
with 10% (vol/vol) methanol/10% (vol/vol) acetic acid at room
temperature. Cells were then stained for 10 min with 1% (wt/vol)
crystal violet (Sigma-Aldrich) in methanol, washed in water and
the absorbed dye was released by incubation with agitation for
1 h at room temperature in methanol containing 0.1% sodium
dodecyl sulfate (SDS). The dye containing solutions were then
transferred to 96-well microtiter plates, and dilutions (1:2) were
prepared. The optical density (OD) at 595 nm was assayed in an
Infinite 200 PRO reader (TECAN).
The XCelligence system was used according to the
manufacturer’s instructions (Ozyme). HCECs were seeded
on electronic microtiter plates (E-Plate) with 6800 cells/well.
After 24 h, when Cell Index (CI) was stable, cells were treated
with CDT. Cell impedance was measured in each well every 1
h for 7 days. Impedance signals were analyzed by an integrated
software (RTCA Analyzer), and expressed as a CI-value that
reflects cell number, cell adhesion and/or cell morphology.
Acquisition and analysis was performed with the RTCA software
(Version 2.0). Experiments were carried out independently in
triplicate.
Immunofluorescence
Cells were grown on glass slide in 6-well plates (100 000
cells/well) for 24 h. After 24 h of CDT treatment, cells were
washed with PBS and fixed with 4% of paraformaldehyde for 20
min. Cells were washed with PBS for 5 min then permeabilized
with 0.5% Triton X-100 in PBS for 15 min. Cells were blocked
with 3% BSA in PBS for 1 h and then incubated with primary
antibodies for 2 h. After three washes, cells were incubated
with secondary antibody for 1 h and nuclei were labeled with
4,6-diamino-2-phenyl indole (DAPI).
For β-catenin and actin staining, after fixation with cold
4% paraformaldehyde, cells were permeabilized (10 min of
0.1%TritonX-100/PBS at room temperature). The saturation
of non-specific fluorescence is performed in 0.1%TritonX-
100/PBS/5% BSA for 15 min. Cells were incubated 2 h with
mouse primary antibody at room temperature. Cells were
incubated with secondary antibody (chicken anti-mouse, Alexa
488) and phalloidin-TRITC for 1 h at room temperature.
Coverslips were mounted with Prolong Gold with DAPI. Slides
were analyzed with a confocal laser-scanning microscope (SP8,
LEICA) equipped with a 63x oil immersion objective and using
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405, 488, and 565 nm lasers to reveal DAPI, Alexa 488 and TRITC
dyes, respectively.
The images were analyzed using ImageJ software.
Micronucleus Assay
Cells with chronic and no chronic treatment were grown in 12-
well plates (5× 104 cells/well) for 48 h. Cells were fixedwith 4% of
paraformaldehyde for 20 min, after a PBS wash. Then cells were
permeabilized with 0.5% Triton X-100 in PBS for 15 min, and
nuclei were stained with DAPI (10 nM).
In-Cell Western
The In-Cell Western technique was previously described to
determine genotoxicity (Graillot et al., 2012). Briefly, cells grown
on PrimariaTM 96-well plates (7 × 103 cells/well) for 24 h. After
24 h of CDT treatment, cells were washed with PBS, and fixed
with 4% paraformaldehyde for 20 min. Paraformaldehyde was
then neutralized with 20 mM NH4Cl for 2 min and washed with
PBS for 5 min. Cells were permeabilized with 0.2% Triton X-100
in PBS for 5 min and washed with PST buffer. Cells were blocked
with MAXblock Blocking Medium (Active Motif, Belgium) with
PHOSSTOP (Roche) for 60min at room temperature followed by
incubation with the primary antibody in PST buffer for 2 h. After
three washes in PST, secondary detection was carried out using
an infrared fluorescent dye conjugated antibody absorbing at 770
nm. For DNA labeling, RedDot in PST was used in combination
with the secondary antibody. After 1 h incubation and three
washes in PST, the DNA and the γH2AX were simultaneously
visualized using an Odyssey Infrared Imaging Scanner (Li-Cor
ScienceTec) with the 680 nm and the 770 nm fluorophores.
Relative fluorescent units for γH2AX per cell were divided by
the fluorescence per cell of the control vehicles to determine
the modification in H2AX phosphorylation compared with the
control. All experiments were carried out independently in
triplicate. The positive control used was etoposide at 10 µM.
Western Blot Analysis
HCEC 1CT and CTA (shRNA-mediated APC knockdown)
cells were washed in ice-cold PBS, scrapped and pelleted
by centrifugation. The whole lysates were collected in
electrophoresis sample buffer containing 50 mM Tris–base/150
mM Nacl (pH 7.5), 1% Triton X100, 2% sodium deoxycholate,
and 2% sodium dodecyl sulfate. Phenylmethylsulfonyl fluoride
(10 mM), dithiothreitol (10 mM), and protease cocktail
inhibitors (1:100) were added extemporary. Lysates were further
homogenized by sonication on ice, and heated at 70◦C for 10
min. Protein concentrations were measured by the Lowry Assay
(Bio-Rad Lab). Protein (50 µg/well) was loaded on Nupage 3–8%
Tris-acetate precast gels (Life Technologies, St Aubin, France).
The proteins were separated after 90 min (130 V continuous) by
using 1X Tris acetate SDS running buffer (Life Technologies).
The proteins were transferred and blotted onto polyvinylidene
fluoride membranes (Fisher Scientific) with Nupage transfer
buffer (1X) supplemented with 10% methanol + 0.1% SDS
(overnight at 4◦C, 15V constant), and blocked in Tris-Buffered
Saline (TBS)/BSA 3%/Tween 0.1% for 1 h. The membrane
was first probed with primary antibodies overnight at 4◦C,
washed with TBS 1X 0.1% Tween and treated with the infrared
dye-conjugated secondary antibody for 1 h. The fluorescent
proteins were visualized using an Odyssey infrared Imaging
Scanner (Li-Cor ScienceTec, les Ullis, France) with 680 and 770
nm fluorophores.
Soft Agar Clonogenicity Assay
In a 6-wells plate coated with a lower layer media containing
Noble agar 0.5%, cells were seeded in medium 0.375%Noble agar
at 5000 cells per well, in triplicate. After 20 days, colonies larger
than 100µm in size were counted in the whole well. Experiments
were performed in three independent experiments.
Statistical Analysis
The results (n ≥ 3) were analyzed using software GraphPad
Prism 4 for Windows. Different responses of treatments and
genotype effect were analyzed by one-way ANOVA (statistical
differences indicated by dollars “$” in the figures) and Student’s
t-test (statistical differences indicated by asterisks “∗” in the
figures). When ANOVA showed a statistically significant effect
(p < 0.05), comparison among data was done using Tukey’s HSD
Post-hoc test.
RESULTS
To study the possible cellular impact of EcolCDT intoxication in
the colon, immortalized non-transformed adult HCECs termed
1CT (“C” for CDK4 and “T” for Telomerase) have been employed
(Roig et al., 2010). Moreover, three isogenic cell lines obtained
from 1CT cells have been used to model different genetic
pathways to CRC (Smith et al., 2002). Two of these cell lines,
either expressing the KRASV12 oncogene or an shRNA directed
against p53 (termed 1CTR and 1CTP, respectively), have already
been characterized (Eskiocak et al., 2011). The third one, termed
1CTA, has been obtained by shRNA-mediated downregulation
of APC (Supplementary Figure 1). The down-expression of APC
(Supplementary Figure 1A) leads to the constitutive activation of
β-catenin (nuclear translocation, Supplementary Figure 1B) and
the actin network disruption (phalloidin staining, Supplementary
Figure 1C). Firstly, the EcolCDT cellular sensitivity was analyzed
by the PrestoBlue viability assay. The 1CT cell line and its three
mutated derivatives show a dose-dependent decrease of cellular
viability with toxin doses from 25 to 75 ng/ml (Figure 1). The
1CT, 1CTA, and 1CTP cell lines exhibit similar CDT sensitivities
with approximately the same LD50 (2.5 ng/ml; Lethal Dose
50, killing 50% of cells in after 72 h of EcolCDT treatment).
However, 1CTR cells were more resistant and show a higher
LD50 (75 ng/ml). These results have been further confirmed
by the crystal violet cell proliferation assay (Figure 4A) after
5 days of CDT exposure. Finally, we followed in real time
the cell index (CI) by XCelligence technology, measuring the
impedance. CI is an arbitrary unit that reflects the number of
cells, cellular adhesion and shape. After seeding, cells were treated
with EcolCDT for 7 days. In Figure 1B are shown representative
curves of CI evolution after treatment of each cell line. The
Figure 1C presents the stabilized cell index after 76 h of treatment
of three independent experiments. The 1CT and 1CTP exhibit
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FIGURE 1 | EcolCDT exposure affects cell viability of human colonic epithelial cells. (A) 1CT, 1CTA, 1CTR, and 1CTP human colonic epithelial cells (HCECs)
were cultured for 3 days in the presence of different doses of EcolCDT (indicated above the graph). Cell viability was assessed using the PrestoBlue Cell Viability
Reagent. Results present the mean ± SEM of at least three independent experiments. (B) Cell Index was measured in real-time and representative cell growth curves
of the first 76 h of CDT treatment are shown. (C) The Cell Index-values at 76 h post-treatment are represented. Results represent the mean ± SD of three
independent experiments; statistical differences were analyzed by a Student’s t-test between the indicated conditions (*P < 0.05; **P < 0.01).
a slower rate of CI increase after CDT exposure, according to a
dose-dependent manner (Figure 1B). Then, the stabilized CI at
76 h reflects this tendency (Figure 1C). Of note, at the lowest
dose, 1CTP has a higher CI than untreated cells, which could
be explained by an increase of cell number, cell adhesion or
distension. 1CTA cells are sensitive at the highest dose, with a
faster rate of CI increase to reach a lower CI when stabilized. In
contrast, 1CTR cells appear more resistant, with a decrease in CI
after 76 h of CDT at 0.25 ng/ml but not at 2.5 ng/ml (Figure 1C).
According to these data, each cell line exhibits singular growth
rates that are differentially impacted by CDT treatments, pointing
out specific responses to CDT for the four HCECs that cannot be
evaluated by a basic viability assay. To conclude, normal HCECs
are sensitive to CDT intoxication, and KRASV12 introduction and
expression confers partial resistance to EcolCDT cytotoxicity.
Many studies have pointed out the ability of CDT to induce
genomic DNA double strand breaks (DSBs) in infected cells
(Jinadasa et al., 2011). Therefore, we investigated DSB formation
induced by EcolCDT in the 1CT cell line and its isogenic
derivatives. Firstly, the proportion of DSB-accumulating cells
after CDT exposure has been quantified by immunofluorescence
studies using an antibody directed against 53BP1, a well-defined
DSB biomarker that form nuclear foci at DSB sites (Vignard et al.,
2013). A 24 h CDT treatment leads to a dose-dependent increase
of damaged cells in the four cell lines (Figures 2A,B). Indeed,
even an exposure to a very low dose of EcolCDT, considered as
subtoxic (25 pg/ml, see Figure 1), induces a slight increase of
DSB-accumulating cells, which is statistically higher compared
to untreated cells in each cell line (Figure 2B). At 2.5 ng/ml
of CDT, almost all cells exhibit 53BP1 foci (Figures 2A,B). In
contrast, cells exposed to 2.5 ng/ml of an inactive form of
CDT (CDTH153A), composed by a CdtB catalytic mutant (Fedor
et al., 2013), do not accumulate DSB (Figures 2A,B). When
comparing the different cell lines, only 1CTP displays statistical
differences, accumulating less damaged cells at 25 pg/ml of CDT,
compared to 1CT (Figure 2B). Based on these data, 1CT and
its derivatives show a dose-dependent augmentation of cells
accumulatingDSB in response to EcolCDT, with 1CTP cells being
less impacted.
Next, to obtain more insight on the response to DNA
damage in the four isogenic cell lines, the phosphorylation of
H2AX on Ser139 (γH2AX), the most common DSB biomarker
(Vignard et al., 2013), was evaluated by In-Cell Western
strategy (Graillot et al., 2012). The use of two different DSB
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FIGURE 2 | EcolCDT exposure induces the 53BP1 recruitment to sites of DNA damage in HCECs. (A) Representative images of 53BP1 immunostaining (red)
in HCECs cells treated with the indicated doses of wild-type CDT or a catalytically dead mutant (CDTH153A) for 24 h. DNA was stained with DAPI (blue). NT represents
non-treated cells. Scale bar = 50 µm. (B) Quantification of HCECs positive for 53BP1 presented in (A). Cells were scored positive when containing more than five
53BP1 foci. Results represent the mean ± SEM of at least four independent experiments; statistical differences were analyzed by a Student’s t-test (indicated by
asterisks) between the indicated conditions, or by one-way ANOVA (indicated by dollars) for multiple comparisons, followed by Tukey’s HSD post-hoc test (* or $ P <
0.05; **P < 0.01; ***P < 0.001).
biomarkers (i.e., 53BP1 and γH2AX) has been validated in 1CT
cells by co-immunofluorescence analyses, showing that both
signals display same patterns of positive cells after treatments
with increasing doses of EcolCDT (Figures 3A,B). However,
the γH2AX background signal is slightly higher compared to
53BP1, probably corresponding to replicative stress signaling
(Figure 3A, see asterisks). Compared to immunofluorescence
observations, no γH2AX signal increase can be detected by In-
Cell Western when cells are exposed to 250 pg/ml of EcolCDT
during 24 h (Figure 3C). This result suggests that the basal
γH2AX level of the HCEC 1CT lineage does not permit to detect
the CDT-induced γH2AX enhancement by In-Cell Western, this
technique allowing global γH2AX signal detection. However,
at 2.5 ng/ml of CDT, the γH2AX signal shows a 1.26-fold
increase in 1CT, 1.63-fold in 1CTA, 1.21-fold in 1CTR, and 1.63-
fold in 1CTP compared to the respective control cells, that is
statistically different from the untreated condition, except for
1CTR. Moreover, the γH2AX signal increase seems higher in
1CTA and 1CTP cells compared to 1CT, even if no statistical
difference can be observed (P = 0.104 for 1CTA and P = 0.0746
for 1CTP). This suggests that the DSB-repair machinery may be
more efficient in 1CT cells compared to 1CTA and 1CTP cells
after induction of DNA damage.
To test this hypothesis, cells were exposed to the DSB-
inducing agent etoposide for 2 h or released in fresh media for
a 16 h recovery time after 1 h of etoposide. The DSB-repair
capacity has been evaluated by the reduction of the γH2AX signal
between these two conditions. After 2 h of etoposide, the γH2AX
signal is enhanced almost three times compared to the basal level
for 1CT, 1CTA, and 1CTR, while it is only enhanced two times
for 1CTP, supporting that the detection and signaling of DSBs
are similar between 1CT, 1CTA, and 1CTR. When 1CT cells are
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FIGURE 3 | EcolCDT exposure induces γH2AX increase in HCECs. (A) Representative images of 53BP1 immunostaining (red) and γH2AX (green) in HCECs
cells treated with the indicated doses of wild-type CDT for 24 h, showing the colocalization of 53BP1 and γH2AX foci (MERGE). DNA was stained with DAPI (blue). NT
represents non-treated cells. White asterisks marks cells with γH2AX staining unrelated to DSB. Scale bar = 20 µm. (B) Quantification of HCECs positive for γH2AX
or 53BP1 presented in (A). Cells were scored positive when containing more than five foci. Results represent the mean ± SEM of at least four independent
experiments. (C) In-Cell Western of γH2AX on HCECs. HCECs were treated with the indicated doses of EcolCDT for 24 h, or treated with 10 µM of etoposide and
released or not in fresh media. Results represent the mean ± SEM of at least four independent experiments; statistical differences were analyzed by a Student’s t-test
between a condition and the non-treated cells or between the indicated conditions (**P < 0.01; ***P < 0.001).
released for 16 h in freshmedia after etoposide, the γH2AX signal
drops to only 1.37-fold increase compared to control cells, which
is statistically different from the etoposide treatment without
recovery time (P < 0.0001) but not from untreated cells (P =
0.054). Thus, 1CT cells seem to efficiently repair DSBs. After
etoposide release, 1CTA cells also displays some DSB repair
capacity but less compared to 1CT: γH2AX signal represent 1.90-
fold increase compared to the basal level (statistically different;
P < 0.05) and is not statistically different from etoposide for 2 h
(P = 0.057). The 1CTR situation is comparable to that of 1CTA,
with even less efficient DSB repair: 1CTR cells released from
etoposide still exhibit a 2.39-fold increase in γH2AX signal that is
close to the 2.94-fold increase for etoposide without release (P =
0.44). Finally, 1CTP cells are defective in DSB signaling because
the γH2AX level after 2 h of etoposide is statistically lower than
for 1CT cells (P < 0.05). Furthermore, 1CTP are also defective
in DSB repair because the γH2AX signal increase is almost the
same between etoposide 2 h and etoposide with release (2.08- and
1.81-fold, respectively; P = 0.36).
Taken together, these data reveal that the higher γH2AX
induction in 1CTA and 1CTP compared to 1CT after EcolCDT is
probably due to impaired DNA damage response, as revealed by
etoposide treatments. 1CTR cells, however, seem defective inDSB
repair but do not appear more damaged than 1CT after CDT.
In mouse, chronic infection with CDT-producing bacteria has
been associated with dysplasia, highlighting a possible role for
CDT during carcinogenesis (Fox et al., 2004; Ge et al., 2007).
To address the question of EcolCDT contribution in acquisition
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FIGURE 4 | Comparative analyses of HCECs chronically exposed or not to EcolCDT. (A,B) HCECs (A) and HCECsCE (B) were exposed for 5 days to
EcolCDT and cell viability was determined by crystal violet staining. NT represents non-treated cells. Results present the mean ± SEM of at least three independent
experiments; statistical differences were analyzed by one-way ANOVA followed by Tukey’s HSD post-hoc test ($$$P < 0.001) (C) Quantification of HCECs and
HCECsCE positive for 53BP1 after a 24 h treatment with EcolCDT. Cells were scored positive when containing more than five 53BP1 foci. Results represent the mean
± SEM of at least three independent experiments. (D–G) In-Cell Western of γH2AX on chronically exposed (HCECsCE) or not (HCECs) 1CT (D), 1CTA (E), 1CTR (F),
or 1CTP (G). HCECs were treated with 0.25 ng/ml of EcolCDT for 24 h, or treated with 10 µM of etoposide and released or not in fresh media. Results represent the
mean ± SEM of at least three independent experiments; statistical differences were analyzed by a Student’s t-test between the indicated conditions (*P < 0.05).
of tumorigenic properties in normal or premalignant HCECs,
we chronically exposed 1CT, 1CTA, 1CTR, and 1CTP cells to
a sublethal dose of CDT (25 pg/ml) for up to 8 weeks. These
cells (termed 1CTCE, 1CTACE, 1CTRCE, and 1CTPCE) display
similar dose-responses compared to non-chronically exposed
cells in crystal violet proliferation assay (Figures 4A,B), with
1CTRCE cells being more resistant (P < 0.0001). In the same way,
the proportion of cells suffering DSBs after a 250 pg/ml CDT
treatment for 24 h, assessed by the counting of 53BP1 positive
cells during immunofluorescence observations, does not vary
between 1CTs and 1CTsCE cells (Figure 4C).
Then, In-Cell Western studies were conducted to analyze
the DSB repair capacities of the chronically exposed cells
(Figures 4D–G). Similar to 53BP1 immunofluorescence
observations, the γH2AX induction after 2.5 ng/ml of EcolCDT
for 24 h does not differ with or without chronic exposure for
the four cell lines. Moreover, similar responses to etoposide
were obtained when comparing 1CT and 1CTCE (Figure 4D)
or when comparing 1CTP and 1CTPCE (Figure 4G). However,
1CTACE cells show drastic changes in response to etoposide
compared to 1CTA (Figure 4E), especially after the recovery
time. Indeed, albeit the γH2AX induction decreased to 1.90-fold
the basal level in 1CTA, it remained to 2.64-fold the basal level in
CTACE, which is statistically different (P < 0.05). Thus, chronic
exposure to CDT seems to perturb the DSB repair capacity
of 1CTA cells. The results for 1CTR are misleading, because
the γH2AX induction appears diminished after release from
etoposide when comparing 1CTR to 1CTRCE (Figure 4F), but
no statistical difference were observed (P = 0.055). To conclude,
chronic exposure to CDT does not appear to specifically modify
the cellular response to CDT but may rather alter the global
response to DNA damage, especially in 1CTA cells.
Defective DNA repair capacities can generate genetic
instabilities, a hallmark of cancer cells. Therefore, the
micronucleus frequency was quantified in untreated control
cells and cells chronically exposed to EcolCDT (Figure 5). While
1.1% of 1CT cells exhibited micronuclei, CDT chronic exposure
induced a 2.5-fold increase of micronucleus-containing cells,
representing 2.7% of the entire population in 1CTCE cells.
This indicates that the subtoxic dose of EcolCDT used for
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FIGURE 5 | Micronucleus frequency in HCECs and HCECsCE. (A) Nuclei
of HCECs and HCECsCE were stained with DAPI. The frequency of cells with
micronuclei (white arrows) was quantified by fluorescence visualization. (B)
Quantification of HCECs with micronuclei presented in (A). Results represent
the mean ± SEM of at least three independent experiments; statistical
differences were analyzed by a Student’s t-test (indicated by asterisks)
between the indicated conditions, or by one-way ANOVA (indicated by dollars)
for multiple comparisons, followed by Tukey’s HSD post-hoc test (** or $$ P <
0.01; *** or $$$ P < 0.001).
chronic exposure is yet sufficient to enhance genetic instability.
The three 1CT derivative cell lines already present a greater
rate of micronucleus-positive cells compared to their parental
counterpart. Indeed, the percentage of cells with micronuclei
is 2.8% for 1CTA (tendency but not significantly different
from 1CT; P = 0.0844), 3.75% for 1CTR (P < 0.0001), and
7.14% for 1CTP (P < 0.001). 1CTACE cells show a 3.6-fold
augmentation of cells with micronuclei compared to 1CTA (P
< 0.01). Micronucleus induction after chronic exposure to CDT
is further enhanced in 1CTRCE that present 5.4 times more cells
with micronuclei compared to 1CTR, reaching to approximately
20% of total cells. Finally, albeit 1CTP cells are the most prone
to genetic instability, the chronic exposure to CDT only induced
a 1.6-fold increase of micronucleus frequency. When analyzing
the effect of chronic exposure according to the genotype of the
cells, it appears that CDT has a stronger effect in CTACE, CTRCE,
and CTPCE compared to 1CTCE (P < 0.01, <0.01, and <0.0001,
respectively). In conclusion, the chronic exposure to EcolCDT
inducesmicronucleus formation onlymodestly in 1CT and 1CTP
cells, and this effect is highly potentiated in 1CTA and 1CTR cells.
Normal epithelial cells cannot proliferate without attachment
to the extracellular matrix, and must acquire the ability to grow
independently of anchorage to become cancer cells. In an attempt
to confirm that the genetic instability caused by chronic exposure
to EcolCDT constitutes a hallmark of malignant transformation,
the soft agar colony assay was conducted in 1CTs vs. 1CTsCE cells
(Figure 6). Under our experimental conditions, 1CT cells are not
able to form colonies in soft agar even when chronically exposed
to CDT. In comparison, 1CTA cells form very few colonies
(non-significant compared to 1CT; P = 0.7838), and this ability
to grow anchorage independently is drastically enhanced after
chronic exposure to CDT, to approximately 10-fold the basal
1CTA level. Compared to 1CT, 1CTR, and 1CTP cells exhibit a
low but slightly higher number of colonies as previously reported
(Eskiocak et al., 2011), with statistical significance (P < 0.01 and
<0.0001, respectively, compared to 1CT). However, they present
different behavior under chronic exposure condition. Similar
to APC deficient cells, 1CTPCE cell ability to grow anchorage
independently was statistically increased compared to 1CTP,
whereas the number of colonies does not change between 1CTR
and 1CTRCE. Thus, anchorage independent growth only depends
on oncogenic KRASV12 expression in 1CTRCE. In 1CTPCE, we
observed a cumulative effect on colony formation dependent on
CDT exposure and p53 downregulation (P < 0.001, 1CTPCE vs.
1CTCE). According to these results, chronic exposure to EcolCDT
cannot by itself promote anchorage-independent growth in
normal HCECs, but require particular precancerous-associated
genetic alterations in APC or TP53 but not in KRAS.
DISCUSSION
In the last decade, there is mounting evidence directly
implicating the human microbiome in carcinogenesis in various
organs (Bultman, 2014). The precise role of CDT in bacterial
pathogenicity is still not fully understood, but experimental
evidences demonstrate in mouse models that production of CDT
by C. jejuni or H. hepaticus is associated with dysplastic changes
in their respective niches (Fox et al., 2004; Ge et al., 2007).
However, little is known concerning the CDT-mediated cellular
defects and the underlying mechanisms that could contribute to
malignant transformation. Transgenic rat embryonic fibroblasts
and human CRC HCT116 cells acquire hallmarks of cancer
after chronic exposure to CDT (Guidi et al., 2013). However,
rat embryonic fibroblasts do not represent the primary target
of CDT-producing bacteria, and HCT116 are already cancer
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FIGURE 6 | Chronic exposure to EcolCDT enhances
anchorage-independent growth in 1CTA and 1CTP but not in 1CT and
1CTR. (A) HCECs and HCECsCE were cultured in soft-agar in 6-well plates
for 3 weeks in triplicates, and colonies larger than 100 µm in size were scored.
(B) Quantification of the soft-agar assay presented in (A). Results represent
the mean ± SEM of three independent experiments; statistical differences
were analyzed by a Student’s t-test (indicated by asterisks) between the
indicated conditions, or by one-way ANOVA (indicated by dollars) for multiple
comparisons, followed by Tukey’s HSD post-hoc test (** or $$ P < 0.01; $$$ P
< 0.001).
cells, implying that other cellular models that are more relevant
are needed to unravel the mechanism of CDT in the initiation
or promotion of malignant transformation. CDT has been
shown to be toxic in a broad range of epithelial cells, and
many clues indicate that CDT can destabilize the epithelial
barrier to promote bacterial colonization (Jinadasa et al., 2011;
DiRienzo, 2014). Therefore, we assessed the impact of EcolCDT
acute or chronic exposure on normal HCECs obtained from
healthy patients (Roig et al., 2010). Moreover, we conducted a
comparative study by analyzing isogenic cells, derived from the
1CT lineage and used these as models of three different genetic
alterations frequently observed in CRC: loss of APC or p53, and
KRASV12 oncogenic activation (Smith et al., 2002). Our results
argue for potential a role of EcolCDT in CRC promotion, but not
initiation, by perturbing different cellular pathways regarding the
precancerous genetic environment.
Our comparative observations of the four HCECs isogenic cell
lines reveal differential effects of EcolCDT when critical tumor
suppressors or oncogene are deregulated. Basically, EcolCDT
displays a dose-dependent cytotoxicity on 1CT cells, associated
to DSB induction signaled by γH2AX increase and 53BP1
accumulation at damaged sites, and micronucleus formation.
These data are in agreement with the CdtB DNase activity and its
associated cellular phenotypes (Bezine et al., 2014). Nevertheless,
we do not exclude that the second characterized CdtB PIP3
phosphatase activity (Shenker et al., 2007, 2016) could play a
role in the HCEC behavior after intoxication with EcolCDT
(see below).
The 1CTA cells are not more sensitive to EcolCDT
compared to control cells, and DSB are formed in similar
kinetics in both entire cell populations regarding 53BP1
immunofluorescence (Figure 2). However, the CDT-induced
γH2AX increase observed by In-Cell Western is greater in 1CTA
than in 1CT (Figure 3C). We previously reported that CDT-
mediated DSB formation increases over time in a cell cycle-
dependent manner (Fedor et al., 2013). As 1CT and 1CTA exhibit
the same proportion of damaged cells after CDT treatments,
this suggests that their proliferation status is similar. Then, the
more pronounced γH2AX increase in 1CTAmight reflect a defect
in DNA repair with loss of APC function. Indeed, the repair
of etoposide-induced DNA damage was less efficient in APC-
defective cells. APC has been implicated in the regulation of
Base Excision Repair, and thus of single strand breaks repair
(Jaiswal et al., 2006). Our previous work strongly suggests that
CDT generates both DSBs and single strand breaks (Fedor et al.,
2013), establishing a possible link between CDT genotoxicity and
APC function.Moreover, APC ensures high-fidelity chromosome
segregation, especially in combination with aneugenic stresses,
and chromosome mis-segregation in APC deficient cells is
most probably associated with DNA damage (Poulton et al.,
2013). CDT induces micronuclei even in the presence of APC,
suggesting that the enhanced chromosome segregation defects
in CDT-exposed 1CTA cells is at least in part responsible for
γH2AX accumulation. Implication of p53 in the response to
EcolCDT-induced DNA damage was not surprising since it has
a well-defined role in DNA damage responses (Toledo andWahl,
2006). Our data support that both 53BP1 accumulation and
γH2AX increase after CDT or etoposide are altered in 1CTP cells,
demonstrating that activation of the DNA damage response by
CDT is impaired through p53 loss in HCEC. In other words, our
results support that the loss of the tumor suppressors APC or p53
sensitize HCECs to CDT-induced genotoxicity.
In contrast, 1CTR cells do not show any defect in 53BP1
foci formation or in γH2AX induction in response to CDT,
suggesting that DSB signaling and repair is not affected by
KRAS oncogenic activation. Moreover, 1CTR are more resistant
to CDT than the three other HCECs. If one assumes that
DNA damage is not responsible for the different CDT-mediated
cellular outcomes between 1CTR and 1CT, then it should
rely on CdtB phosphatase activity. CdtB hydrolyses PIP3 to
phosphatidylinositol-3,4-biphosphate and thus alters the PI-3K/
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PIP3/Akt/pGSK3β signaling pathway (Shenker et al., 2007,
2016). Intracellular PIP3 is primarily synthetized by PI-3Ks
and regulates a variety of physiological processes including cell
proliferation, cell survival, and intracellular vesicle trafficking
(Manna and Jain, 2015). Interestingly, PI-3K is one of the main
effector of KRAS, suggesting that the oncogenic activation of
KRAS in 1CTR cells enhance the pool of intracellular PIP3,
the substrate of the CdtB phosphatase activity. According to
the vast spectrum of processes regulated by phosphoinositides
(Sasaki et al., 2007), it is therefore tempting to speculate that the
concomitant PI-3K overactivation and CdtB phosphatase activity
in 1CTR exposed to CDT will affect numerous downstream
physiological functions.
Thus, chronic exposure to EcolCDT should induce distinct
cellular defects in the fourHCECs cell lines, especially concerning
malignant transformation. 1CT cells, considered as normal
HCEC, only display modest changes after being chronically
exposed to EcolCDT. Indeed, albeit micronucleus frequency
slightly increased in 1CTCE compared to 1CT, they show
identical DNA damage responses and are not able to grow
anchorage independently. This suggests that chronic exposure of
normal HCEC to EcolCDT is not a potent initiator of CRC. In
contrast, our observations indicate that 1CTACE acquire different
hallmarks of cancer, as they display an altered DNA damage
response and a greater enhancement of chromosomal instability
and anchorage-independent growth. These cellular phenotypes
may be a consequence of APC loss-related sensitization to the
DNA damage induced by CDT. Alternatively, it may be due to
the cumulative effect of APC deficiency and CDT-induced DSBs
on cytoskeleton, both of which destabilizing the actin network
(Fearnhead et al., 2001; Frisan et al., 2003; Supplementary Figure
1C). 1CTR and 1CTP cells already exhibit signs of malignant
transformation, with spontaneous micronuclei formation and
the ability to grow anchorage independently. Furthermore, p53
deficiency intrinsically perturbs the DNA damage response
(Toledo and Wahl, 2006). CDT chronic exposure augments
anchorage-independent growth of 1CTP but has limited effects
on chromosomal instability. Importantly the micronucleus
basal level is relatively high in 1CTP, probably due to the
genotoxic stresses inherent to the cell culture conditions. The
CDT-mediated effects on chromosome mis-segregation might
thus be partially masked. In contrast, 1CTR ability to grow
anchorage independently is not impacted by chronic exposure
to CDT, whereas micronucleus frequency dramatically increased
compared to all other cell lines. These data suggest that
the cumulative effects of PI-3K overactivation induced by
KRASV12 expression and of CdtB phosphatase activity modify
the phosphoinositide pool content in a way that will ultimately
affect chromosome segregation. Deciphering the molecular
mechanisms that drive these genetic alterations will be of great
interest to gain a better understanding of the cellular impact
of CdtB phosphatase activity on the tumor microenvironment
involving PI-3K pathway alterations.
The Fearon and Vogelstein genetic model of CRC
carcinogenesis predicts the sequential mutation of specific
genes initiated by the mutations of the APC gene followed by
mutations on KRAS and on TP53 (Fearon and Vogelstein, 1990).
However, a genetic study of a CRC patient cohort revealed that
these mutations could occur independently in tumors, especially
the association of mutations in TP53 and KRAS (Smith et al.,
2002). More generally, the combinations of KRAS mutation
with APC and/or TP53 are represented in only 20% of the
CRC tumors. In contrast, the most common combination of
mutations affected APC and TP53.
Interestingly, these observations correlate with our findings
that EcolCDT may affect 1CTR through a mechanism different
from 1CTA and 1CTP.
Overall, these results strongly suggest that EcolCDT cannot
efficiently initiate CRC carcinogenesis by itself. To support this
statement, CDT production by C. jejuni or H. hepaticus has been
associated to dysplasia only after infection of NF-κB-deficient
mice or liver disease-susceptible mice, respectively (Fox et al.,
2004; Ge et al., 2007). The present study favors a role of EcolCDT
in CRC promotion in genetically altered precancerous HCECs.
APC gene mutations are found in 50–80% of sporadic CRC
and are considered as early initiating events (Fearnhead et al.,
2001). Intriguingly, our observations indicate that the more
pronounced malignant transformation after chronic exposure to
EcolCDT concerned the APC-deficient HCEC. Therefore, CDT
production by pathogenic bacteria should be an aggravating
factor in a majority of CRC susceptible genetic backgrounds.
Besides, the alternative genetic pathways may also be affected, at
least those implying TP53 or KRASmutations. Finally, CDT does
not represent the unique virulent factor produced by pathogenic
E. coli. CDT association to CRC has been observed from E. coli
strains harboring other cell cycle destabilizing toxins (Buc et al.,
2013; Bonnet et al., 2014), strengthening the postulate that CDT
incidence in CRC is a part of a multifactorial process.
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